These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 10806619)

  • 21. Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein-Barr virus reactivation.
    Fukuda M; Kurosaki H; Sairenji T
    J Med Virol; 2006 Nov; 78(11):1456-64. PubMed ID: 16998876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations of transforming growth factor beta receptor II, insulin growth factor receptor II genes in microsatellite unstable prostate carcinomas.
    Bhattacharyya N; Tao J; Klein EA; Banerjee S
    Oncol Rep; 2004 Jan; 11(1):231-6. PubMed ID: 14654931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells.
    Ota T; Fujii M; Sugizaki T; Ishii M; Miyazawa K; Aburatani H; Miyazono K
    J Cell Physiol; 2002 Dec; 193(3):299-318. PubMed ID: 12384983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblasts from chronic wounds show altered TGF-beta-signaling and decreased TGF-beta Type II receptor expression.
    Kim BC; Kim HT; Park SH; Cha JS; Yufit T; Kim SJ; Falanga V
    J Cell Physiol; 2003 Jun; 195(3):331-6. PubMed ID: 12704642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
    Chen A
    Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered expression of the receptor and ligand in the TGF beta signaling pathway in diffusely infiltrating colon carcinoma.
    Nagayama S; Onodera H; Toguchida J; Imamura M
    Anticancer Res; 2002; 22(6B):3545-54. PubMed ID: 12552954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.
    Fukushima T; Mashiko M; Takita K; Otake T; Endo Y; Sekikawa K; Takenoshita S
    J Exp Clin Cancer Res; 2003 Jun; 22(2):315-20. PubMed ID: 12866583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of the type II transforming growth factor-beta receptor inhibits fibroblasts proliferation and activates extracellular signal regulated kinase and c-Jun N-terminal kinase.
    Goldberg HJ; Huszár T; Mózes MM; Rosivall L; Mucsi I
    Cell Biol Int; 2002; 26(2):165-74. PubMed ID: 11846446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion of one adenine base within the polyadenine tract of transforming growth factor-beta receptor type II in human MDA-MB-231 breast cancer cell line.
    Park B; Jang JS; Park K
    Int J Oncol; 2000 Sep; 17(3):473-8. PubMed ID: 10938386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of recombinant extracellular domain of the type II transforming growth factor-beta receptor: utilization in a modified enzyme-linked immunoabsorbent assay to screen TGF-beta agonists and antagonists.
    Fahey MS; Dawbarn D; Allen SJ; Paterson IC; Prime SS
    Anal Biochem; 2001 Mar; 290(2):272-6. PubMed ID: 11237329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
    Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H
    J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
    Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation detection in the TGF-beta receptors and smad genes: RT-PCR and sequencing.
    Myeroff LL; He H; Fink SP; Markowitz S
    Methods Mol Biol; 2000; 142():139-47. PubMed ID: 10806620
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection of TGF-beta type II receptor hot-spot mutations: the BAT-RII assay.
    Myeroff LL; Markowitz S
    Methods Mol Biol; 2000; 142():133-7. PubMed ID: 10806619
    [No Abstract]   [Full Text] [Related]  

  • 36. Microsatellite instability(MSI) in non-small cell lung cancer(NSCLC) is highly associated with transforming growth factor-beta type II receptor(TGF-beta RII) frameshift mutation.
    Kim WS; Park C; Hong SK; Park BK; Kim HS; Park K
    Anticancer Res; 2000; 20(3A):1499-502. PubMed ID: 10928062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.
    Grady WM; Myeroff LL; Swinler SE; Rajput A; Thiagalingam S; Lutterbaugh JD; Neumann A; Brattain MG; Chang J; Kim SJ; Kinzler KW; Vogelstein B; Willson JK; Markowitz S
    Cancer Res; 1999 Jan; 59(2):320-4. PubMed ID: 9927040
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.